This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Topic Collections  • Oncology  • Lung Cancer  • Pulmonary Diseases  • Pulmonary Diseases, Other  • Diagnosis  • Alert me on articles by topic  Social Bookmarking   What's this?

Tracy Hampton, PhD

JAMA. 2007;298(17):1997.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Atlanta—Because about 90% of all lung cancer cases are caused by smoking but only 10% to 15% of heavy smokers will develop the disease, researchers are developing new and sensitive detection techniques to better identify those individuals at highest risk. The tests may also help spot nonsmokers who are at risk due to other factors, such as heredity.

Researchers presenting findings on some of these efforts at the American Association for Cancer Research's second International Conference on Molecular Diagnostics in Cancer Therapeutic Development stressed that new tests are needed because current screening technologies such as high-resolution coaxial tomography often detect lung cancer at later stages. Approximately 213 000 people in the United States are expected to be diagnosed with the disease this year, and more than 160 000 deaths are anticipated.

Scientists are developing new and sensitive detection techniques to better identify individuals at highest risk for lung . . . [Full Text of this Article]

ONCOGENE DETECTION



CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?